OpenFilings

Amylyx Pharmaceuticals, Inc.

Form10-Q

Report Period2024-09-30

Date Filed2024-11-07

Time Filed08:22:41

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-31.1
EX-31.2
EX-31.3
EX-32.1
EX-32.2
EX-32.3
Filing on SEC Edgar